These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9635630)

  • 1. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study.
    Mathias JR; Clench MH; Abell TL; Koch KL; Lehman G; Robinson M; Rothstein R; Snape WJ
    Dig Dis Sci; 1998 Jun; 43(6):1347-55. PubMed ID: 9635630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study.
    Mathias JR; Clench MH; Reeves-Darby VG; Fox LM; Hsu PH; Roberts PH; Smith LL; Stiglich NJ
    Dig Dis Sci; 1994 Jun; 39(6):1155-62. PubMed ID: 8200247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of leuprolide acetate in patients with functional bowel disease. Long-term follow-up after double-blind, placebo-controlled study.
    Mathias JR; Clench MH; Roberts PH; Reeves-Darby VG
    Dig Dis Sci; 1994 Jun; 39(6):1163-70. PubMed ID: 8200248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.
    Hornstein MD; Surrey ES; Weisberg GW; Casino LA
    Obstet Gynecol; 1998 Jan; 91(1):16-24. PubMed ID: 9464714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Debilitating "functional" bowel disease controlled by leuprolide acetate, gonadotropin-releasing hormone (GnRH) analog.
    Mathias JR; Ferguson KL; Clench MH
    Dig Dis Sci; 1989 May; 34(5):761-6. PubMed ID: 2496961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks.
    Bowen RL; Perry G; Xiong C; Smith MA; Atwood CS
    J Alzheimers Dis; 2015; 44(2):549-60. PubMed ID: 25310993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group.
    Dlugi AM; Miller JD; Knittle J
    Fertil Steril; 1990 Sep; 54(3):419-27. PubMed ID: 2118858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity vasculitis associated with leuprolide (Lupron).
    Gnanaraj J; Saif MW
    Cutan Ocul Toxicol; 2010 Sep; 29(3):224-7. PubMed ID: 20470239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group.
    Stovall TG; Muneyyirci-Delale O; Summitt RL; Scialli AR
    Obstet Gynecol; 1995 Jul; 86(1):65-71. PubMed ID: 7784025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group.
    Wheeler JM; Knittle JD; Miller JD
    Am J Obstet Gynecol; 1993 Jul; 169(1):26-33. PubMed ID: 8333471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial.
    Mitchell SA; Mee AS; Smith GD; Palmer KR; Chapman RW
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1187-95. PubMed ID: 12030962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
    Palomba S; Orio F; Falbo A; Oppedisano R; Tolino A; Zullo F
    Fertil Steril; 2008 Jul; 90(1):165-73. PubMed ID: 18001721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome.
    Palomba S; Orio F; Manguso F; Russo T; Falbo A; Lombardi G; Doldo P; Zullo F
    Fertil Steril; 2005 Apr; 83(4):1012-20. PubMed ID: 15820814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group.
    Fertil Steril; 1996 Dec; 66(6):911-9. PubMed ID: 8941054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study.
    Klotz LH; McNeill IY; Kebabdjian M; Zhang L; Chin JL;
    Eur Urol; 2013 May; 63(5):927-35. PubMed ID: 23040208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial.
    Miller JD
    Am J Obstet Gynecol; 2000 Jun; 182(6):1483-8. PubMed ID: 10871469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.